AstraZeneca: building a new ‘open innovation’ pharma company

AstraZeneca: building a new ‘open innovation’ pharma company

Source: 
PM Live
snippet: 

The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects